HIV
and AIDS Top News Articles
|
|
|
 NEW
REPORT - First-line
Antiretroviral Therapy for People
with HIV Infection |
 Raltegravir
(Isentress) Has Durable Antiviral Activity and Remains
Well-tolerated after 3 Years
11-3-2009
|
 Longer
STEP Follow-up Suggests Adenovirus
HIV Vaccine Did Not Increase Infection Risk, May
Lower Viral Set-point
11-3-2009
|
 President
Obama Signs Ryan White Act, HIV Travel
and Immigration Ban Will Be Lifted Early Next Year
11-3-2009
|
Raltegravir
(Isentress), Etravirine (Intelence), and Boosted Darunavir (Prezista)
Is Effective for Heavily Treatment-experienced Patients
10-30-2009
|
 Three-quarters
of HIV Positive Prisoners
Decrease Adherence to Antiretroviral Therapy after Release
10-30-2009
|
 Traditional
Pap Smears Work as well as ThinPrep Cytology Test for Detecting
Precancerous Cervical Cell Changes
10-30-2009
|
Additional
ALVAC/AIDSVAX HIV Vaccine
Data Show Only Modest Benefit with Minimal Statistical Significance
10-23-2009
|
Abacavir
(Ziagen) May Contribute to Impaired Endothelial Function
in HIV Patients with Suppressed Viral Load
10-23-2009
|
Does
Endothelial Function Decline
after Starting Antiretroviral Therapy?
10-23-2009
|
 U.S.
House and Senate Pass Ryan White Extension
Act, Ensuring Continued HIV/AIDS Funding
10-23-2009
|
 Is
It Possible to Eliminate Tuberculosis?
10-23-2009
|
Does
Virological Response to Antiretroviral
Therapy Differ between African-American and White
HIV Patients?
10-20-2009
|
Hispanic
and Black Patients -- Especially Immigrants -- May Be Less Likely
to Achieve Complete HIV Treatment Adherence
10-20-2009
|
 Successful
Treatment of Facial Lipoatrophy
with a New Formulation of Hyaluronic
Acid (Restylane SubQ)
10-20-2009
|
 FDA
Approves Gardasil Human Papillomavirus Vaccine for
Boys and Young Men, Cervarix for Girls and Young Women
10-20-2009
|
 Analysis
of H1N1 Swine Flu Cases
in Mexico and Canada Shows Rapid Progression, Young Adults More
Likely to Develop Severe Illness
10-20-2009
|
Raltegravir
(Isentress) and Darunavir
(Prezista) Appear to Reach Therapeutic Levels in
Cerebrospinal Fluid
10-16-2009
|
 Topical
Trichloroacetic Acid Is Safe and Effective for Pre-cancerous
Anal Lesions in Men with HIV
10-16-2009
|
Small
Molecule Compound 5HN Flushes Out Latent HIV in Reservoir
CD4 T-cells
10-16-2009
|
NIH
Starts Trial of H1N1 "Swine"
Flu Vaccine in Pregnant Women, Will Soon Study HIV
Positive Youth and People with Asthma
10-16-2009
|
 October
15 Is Latino AIDS Awareness Day
10-13-2009
|
 FDA
Advisory Committee Recommends Approval of CCR5 Antagonist Maraviroc
(Selzentry) for Treatment-naive Patients
10-13-2009
|
 Menopause
May Occur Earlier in HIV Positive Women
but Does Not Affect Treatment Response
10-13-2009
|
 Latest
ADAP Figures
Show Increasing Demand and More People on Waiting Lists for
HIV Drugs
10-13-2009
|
 Chronic
Fatigue Syndrome
Linked to Infectious Retrovirus XMRV
10-13-2009 |
FDA
Issues Updates for Health Professionals on Vaccines and Antiviral
Medications for H1N1 Influenza (Swine
Flu)
10-13-2009
|
 HIV
Patients with a CD4 Cell Count Below 500 Cells/mm3 Are at Increased
Risk for Cancer
10-09-2009
|
Meta-Analysis
of Truvada vs Epzicom Backbones
Used with Boosted Protease Inhibitors
for First-line Antiretroviral Therapy
10-09-2009 |
 HIV
Positive People Are at Higher Risk
for Cancer, especially Malignancies Linked to Infectious
Pathogens or Smoking
10-09-2009 |
 Effective
Antiretroviral Therapy Leads to Improved
Lung Function in People with HIV
10-09-2009 |
 Avexa
Closes Trial of Experimental NRTI Apricitabine,
Will Evaluate 24-week Data
10-09-2009 |
FDA
Announces Authorization of 100th Generic Antiretroviral Product
for Use under PEPFAR
10-09-2009 |
Boehringer
Ingelheim Announces Co-Pay Rebate Program for Nevirapine
(Viramune)
10-09-2009 |
Level
of Treatment Adherence Needed
to Keep HIV Undetectable May Decline Over Time
10-06-2009 |
Raltegravir
(Isentress), Etravirine (Intelence), and Ritonavir-boosted Darunavir
(Prezista) Is a Safe and Successful Salvage Regimen
10-06-2009 |
Monoclonal
Antibody PRO 140 Demonstrates Good Tolerability and
Potent Activity against CCR5-tropic HIV
10-06-2009 |
Variations
in "SEVI" Semen Component
May Help Explain Racial/ethnic Differences in HIV Transmission
Rates
10-06-2009 |
New
Global Report Indicates
that More than 4 Million People Worldwide Received Antiretroviral
Therapy at the End of 2008
10-06-2009 |
White
House AIDS Office Announces Upcoming National
HIV/AIDS Community Discussions
10-06-2009 |
First
Shipments of H1N1 Vaccine
Are Released and Oseltamivir (Tamiflu) Distribution Widens as
"Swine Flu" Spreads
10-06-2009 |
Raltegravir
(Isentress) plus Atazanavir (Reyataz) Maintenance
Therapy Appears Safe and Effective in Small Study
10-02-2009 |
Short-term
Enfuvirtide (Fuzeon) May
Promote Long-term CD4 Cell Recovery in Patients Who Start Treatment
Late
10-02-2009 |
People
Who Decline Routine HIV Testing
Are More Likely to Be Positive; Written Consent Requirement
May Discourage Testing
10-02-2009 |
 Senate
Committee Unanimously Passes Ryan White
HIV/AIDS Funding Extension
10-02-2009 |
Phase
3 Study in Thailand Shows First Evidence that HIV
Vaccine Can Reduce Rate of Infection
9-25-2009 |
HIV
Maturation Inhibitor Bevirimat Demonstrates Promising
Safety and Efficacy in Patients with Responsive HIV Genotype
9-25-2009 |
 Sunday
is National Gay Men's HIV/AIDS Awareness Day
9-25-2009 |
FDA
Approves New Abbott Prism Automated
Test for Screening Donated Blood and Organs for HIV
9-25-2009 |
 SB
486 Would Make Safe Needle Disposal a Shared Responsibility
9-25-2009 |
Early
Studies Demonstrate Potent Activity and Safety of Experimental
Integrase Inhibitor S/GSK1265744
9-22-2009 |
Once
Daily Raltegravir (Isentress)
Shows Promise in Pilot Study
9-22-2009 |
Nevirapine
(Viramune) and Boosted Atazanavir (Reyataz) Produce
Comparable Early Virological and Immunological Response
9-22-2009 |
Nutritional
Formula Reduces CD4 Cell Decline in HIV Positive
People Not Yet Taking Antiretroviral Therapy
9-22-2009 |
New
Injectable Drug Peramivir Is as Effective as Oseltamivir
(Tamiflu) for Seasonal Influenza
9-22-2009 |
 New
Clinical Trial Tests Tenofovir Vaginal
Gel and Truvada Tablets as HIV Prevention Strategy
for Women in Africa
9-22-2009 |
 Current
Guidelines Need to Be Changed for Both First-line
Treatment and Re-treatment of Tuberculosis, Experts
Say
9-18-2009 |
European
Commission Approves Raltegravir (Isentress)
and Once-daily Lopinavir/ritonavir
(Kaletra) for First-Line HIV Therapy
9-18-2009 |
IL-7
Improves CD4 and CD8 T-Cell Recovery among HIV Patients
on Suppressive Antiretroviral Therapy
9-18-2009 |
GRACE
Trial shows Women Respond as well as Men to Etravirine
(Intelence), but Blacks May Have Poorer Outcomes
than Whites
9-18-2009 |
FDA
Approves Four Vaccines for 2009 H1N1
Influenza (Swine Flu) Virus
9-18-2009 |
CCR5
Antagonist Vicriviroc Demonstrates
Long-Term Safety and Efficacy at 96 Weeks
9-15-2009 |
At
96 Weeks, Raltegravir (Isentress)
Is as Effective as Efavirenz (Sustiva)
in Suppressing HIV Viral Load and Improving Immune Function
9-15-2009 |
Tobacco
and Marijuana May Significantly Lower Atazanavir
(Reyataz) Blood Levels
9-15-2009 |
Antiretroviral
Pregnancy Registry Indicates Use of Tenofovir
(Viread) by Pregnant Women Does Not Raise Risk of
Birth Defects
9-15-2009 |
Study
Shows Strong Immune Response after a Single Dose of Vaccine
for 2009 H1N1 Influenza A ("Swine
Flu")
9-15-2009 |
NIH
Statement on Preliminary Results from Clinical Trials of H1N1
Influenza Vaccines
9-15-2009 |
H1N1
"Swine Flu" Epidemic
in the U.S. May Peak before Adequate Supplies of Vaccine Become
Available
9-15-2009 |
AIDS
Activists Issue Grades to Drug Companies
9-11-2009 |
HIV
Infection Sharply Increases Risk of
Atherosclerosis, but Antiretroviral Therapy Has a
Minor Effect
9-11-2009 |
 Artery
Elasticity Is Reduced in People with Untreated HIV
Infection
9-11-2009 |
Newly
Discovered Neutralizing Antibodies Suggest Novel HIV
Vaccine Approach
9-11-2009 |
 Tenofovir/emtricitabine
plus Lopinavir/ritonavir (Kaletra) or Raltegravir (Isentress)
Work Well for Post-exposure Prophylaxis
9-11-2009 |
 Alcohol
Use Linked to Poor Adherence to Antiretroviral Therapy
9-04-2009 |
Study
Suggests Women's Immune Response to
HIV May Be Less Effective than Men's
9-04-2009 |
 Does
Circumcision Lower the
Risk of HIV Transmission
for Gay and Bisexual Men?
9-04-2009 |
 Sharp
Drop in HIV-related Deaths Contributes to Improved
U.S. Life Expectancy
9-04-2009 |
HIV
Infection Does Not Appear To Be a Risk Factor for H1N1
Influenza Death, but Vaccine May Be Advisable
9-04-2009 |
Tibotec
and FDA Issue New Safety Warning for NNRTI Etravirine
(Intelence) regarding Severe Skin Rash and Hypersensitivity
9-01-2009 |
Studies
Provide New Data on Links between Antiretroviral
Therapy and Bone Loss in People with HIV
9-01-2009 |
Vitamin
D Deficiency is Common among HIV Positive People
and Is Associated with NNRTI Use, Black Race, and Smoking
9-01-2009 |
 Does
Vitamin D Deficiency Increase the Risk of Mother-to-child
HIV Transmission?
9-01-2009 |
 MMWR
Publishes Updated Guidelines
for Prevention and Treatment of Opportunistic Infections in
Children
9-01-2009 |
Researchers
Decode Complete HIV Genome Structure
9-01-2009 |
Abacavir
(Ziagen) Backbone Suppresses HIV as well as Tenofovir
(Viread) in UK CHIC Study
8-21-2009 |
Advent
of Antiretroviral Therapy
Has Not Slowed Rise in Incidence of Anal
Cancer among People with HIV
8-21-2009 |
Anal
Cancer Treatment Is Equally Effective for HIV Positive
and HIV Negative People
8-21-2009 |
|
|
Stepped
Dosing of Efavirenz (Sustiva)
May Reduce Side Effects
8-18-2009 |
Lipid
and Glucose Changes Related to Boosted
Darunavir (Prezista) in Children and Adolescents
with HIV: DELPHI Study
8-18-2009 |
FDA
Grants Tentative Approval of Generic Fixed-dose Combination
of Efavirenz/emtricitabine/tenofovir
8-18-2009 |
How
Infectiousness of Tuberculosis
Patients Coinfected with HIV?
8-18-2009 |
New
Drug-resistant Tuberculosis
Strains Could Become Widespread
8-18-2009 |
CDC
Advisory Panel Recommends H1N1 Influenza
Vaccine Priorities
8-18-2009 |
ARIES
Trial Shows Unboosted Atazanavir (Reyataz)
Maintains Viral Suppression as well as Boosted Drug
8-14-2009 |
 Having
AIDS Raises Risk of HPV-related Malignancies,
including Cervical and Anal Cancer
8-14-2009 |
 Many
HIV Positive Women Do Not Receive Recommended Regular Pap
Smears for Cervical Cancer
8-14-2009 |
Agencies
Release New Report on State of HIV
Prevention Across the U.S.
8-14-2009 |
FDA
Changes Regulations for Expanded Access
to Investigational Drugs
8-14-2009 |
 NIAID
Researchers Look at Past Influenza Pandemics to Help Predict
Course of 2009 H1N1 Influenza (Swine
Flu)
8-14-2009 |
STARTMRK
Trial Shows Raltegravir (Isentress)
Works as Well as Efavirenz (Sustiva)
in Treatment-naive HIV Patients
8-11-2009 |
Presence
of Human Papillomavirus (HPV)
Increases Risk of HIV Infection
8-11-2009 |
 Merck
and Schering-Plough Shareholders Approved Pending
Merger
8-11-2009 |
 IDSA
Publishes Updated Primary Care Guidelines
for People with HIV
8-7-2009 |
FOTO
Study Finds 5 Days On, 2 Days Off Treatment Strategy
Maintains HIV Suppression while Reducing Cost
8-7-2009 |
HIV
Positive People without Viral Hepatitis or Other
Risk Factors Have a Fibrosis Distribution Similar to the General
Population
8-7-2009 |
Immune
Systems of People with Untreated HIV infection May
Deteriorate More Quickly than Previously Thought
8-7-2009 |
 French
Researchers Find New HIV-1 Strain,
Closely Related to a Gorilla Virus, in a Woman from Cameroon
8-7-2009 |
 President
Clinton, Pfizer and Mylan Agreement Will Provide Lower
Cost Medications for People with HIV in Developing
Countries
8-7-2009 |
Antiretroviral
Therapy for Mothers Improves Pregnancy Outcomes and
Reduces Risk of HIV Transmission via Breast-feeding
8-4-2009 |
Treatment-naive
Patients with Confirmed CCR5-tropic HIV Continue to Respond
Well to Maraviroc (Selzentry)
at 96 Weeks in the MERIT Study
8-4-2009 |
Genotypic
Testing Predicts Response to Maraviroc
(Selzentry) as well as Viral Tropism Testing
8-4-2009 |
Liver
Toxicity Related to Raltegravir (Isentress)
Is Uncommon among HIV Patients, including those with HIV-HCV
Coinfection
8-4-2009 |
At
96 Weeks, Epzicom and Truvada
Demonstrate Comparable Efficacy, Safety, and Tolerability when
Combined with Lopinavir/ritonavir (Kaletra)
8-4-2009 |
Even
after Treatment with Acyclovir,
Genital Herpes Significantly Increases the Risk of HIV Infection
8-4-2009 |
Once-daily
Lopinavir/ritonavir (Kaletra)
Works as Well as Twice-daily dosing in Treatment-naive HIV Patients
7-31-2009 |
Can
People in Low-income Countries Benefit from
Antiretroviral Therapy without Routine Laboratory
Monitoring?
7-31-2009 |
Impact
of Adverse Events on Survival of African
HIV Patients in the DART Trial
7-31-2009 |
 Gov.
Schwarzenegger Slashes California State
Funding for HIV Prevention and Monitoring among Other
Health Cuts
7-31-2009 |
FDA
Issues Warning Regarding Body-building Products Containing
Steroids or Similar Substances
7-31-2009 |
Confounding
Factors May Explain Elevated Cardiovascular Risk in Patients
Taking Abacavir
7-28-2009 |
Nevirapine
(Viramune) Has Equal Efficacy but a More Favorable
Lipid Profile Compared with Boosted
Atazanavir (Reyataz)
7-28-2009 |
Daily
Acyclovir (Zovirax) Delays
HIV Disease Progression in People Coinfected with HIV
and Herpes Simplex Virus Type 2
7-28-2009 |
Longer
Duration of HIV Infection and Detectable Viral Load Linked to
Higher Risk of Non-AIDS-defining Cancers
7-28-2009 |
NIAID
to Begin Clinical Trials of H1N1 Influenza
(Swine Flu) Vaccine Candidates
7-28-2009 |
Potent
Next-generation Experimental Integrase
Inhibitor S/GSK134957 Debuts at IAS 2009
7-24-2009 |
Boosted
Darunavir (Prezista) Monotherapy May Be a Viable
Alternative for Patients with Stable Suppressed Viral Load
7-24-2009 |
Intensive
Cardiovascular Intervention Lowers Blood Lipids in
HIV Patients on Antiretroviral Therapy
7-24-2009 |
IAS
2009 Opening Session Emphasizes Need for Expanded Treatment
of HIV and Tuberculosis
in Developing Countries
7-24-2009 |
Research
Offers Guidance on Scaling Up HIV and
Tuberculosis Treatment Programs in Resource-limited
Countries
7-24-2009 |
Widespread
Use of Antiretroviral Therapy
Associated with a Large Decrease in Tuberculosis
Prevalence in South Africa
7-24-2009 |
At
Opening of International AIDS Conference in South Africa, Scientists
Warn against Cutting Back Funding for
AIDS Programs
7-21-2009 |
Large
Numbers of Women and People of Color Can Be Successfully Enrolled
in HIV Studies in U.S.
7-21-2009 |
Once
Daily Darunavir/ritonavir:
Experience in a Single Centre
7-21-2009 |
HIV
Latency Is a Myth: New HIV Paradigm May Focus on
Inflammation
7-21-2009 |
Integrase
Inhibitor Raltegravir (Isentress) Compares Favorably
to Efavirenz (Sustiva) at 144 Weeks in Treatment-naive Patients
7-21-2009 |
Male
Circumcision Does Not Reduce Risk of HIV Transmission
to Women
7-21-2009 |
Schering-Plough
Expands Phase 2 Study of Experimental
CCR5 Antagonist Vicriviroc
7-21-2009 |
World
Health Organization Stops Tracking Laboratory-confirmed Cases
of H1N1 Swine Flu
7-21-2009 |
GlaxoSmithKline
Announces $80 Million Funding Program with a Special Focus on
Treatment and Care for Children in
Africa
7-21-2009 |
 World
Health Organization (WHO) Says the BCG
Tuberculosis Vaccine Is Too Dangerous for HIV Positive
Infants
7-14-2009 |
International
AIDS Society Conference Begins
Sunday, July 19, in Cape Town, South Africa
7-14-2009 |
 Does
Antiretroviral Therapy Improve Neurocognitive
Performance in People with HIV?
7-14-2009 |
 Kaiser
Family Foundation and UNAIDS Issue AIDS
Funding Report
7-14-2009 |
A
Review of the Experimental NNRTI Rilpivirine
7-10-2009 |
 Switching
from Lopinavir/ritonavir (Kaletra)
to Boosted Atazanavir (Reyataz)
Reduces Visceral Fat and Improves Glucose Metabolism
7-10-2009 |
Laboratory
Study Helps Explain Why People with HIV Are More Susceptible
to Tuberculosis
7-10-2009 |
FDA-approves
Raltegravir (Isentress)
for Therapy in Treatment-naive HIV Patients
7-10-2009 |
Open
Enrollment for Study of Oral Drug Eltrombopag
to Reduce the Need for Platelet Transfusions in Patients with
Liver Disease
7-10-2009 |
Could
a Combination Treatment Strategy Eradicate
HIV?
7-07-2009 |
Earlier
Antiretroviral Therapy Reduces Disease Progression and Death
in a Resource-limited Country
7-07-2009 |
 HIV
Infection Itself Does Not Affect the Risk of Developing
Diabetes, but HIV-HCV Coinfection Plays a Role
7-07-2009 |
Strong
Relationship between 1918 Influenza Virus and 2009
H1N1 Flu
7-03-2009 |
Early
Antiretroviral Therapy May Protect against HIV-related
Brain Dysfunction
7-03-2009 |
 Long-term
Testosterone Therapy Is
Safe and Improves Body Composition in Women with HIV
7-03-2009 |
 Many
HIV Positive People in the U.S. Are
Not Tested until Late Stages of Disease
7-03-2009 |
 DHHS
Issues Proposed Regulations to Remove
Ban on HIV Positive Visitors and Immigrants
7-03-2009 |
Newer
Anti-HIV Drugs
and How to Use Them: Part 2
6-26-2009 |
| |
